Piedmont Investment Advisors’s Inogen INGN Stock Holding History

Piedmont Investment Advisors’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,059	Closed	-$756K	–	1640
2018 Q2	$756K	Buy	4,059 +361	+10%	+$60.1K	0.04%	344
2018 Q1	$454K	Buy	3,698 +180	+5%	+$22K	0.01%	443
2017 Q4	$419K	Sell	3,518 -184	-5%	-$20.3K	0.01%	465
2017 Q3	$352K	Buy	3,702 +185	+5%	+$17.8K	0.01%	519
2017 Q2	$336K	Buy	+3,517	New	+$301K	0.01%	525

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Piedmont Investment Advisors's INGN Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Inogen (INGN) in Q3 2018, closing a stake of 4,059 shares — an estimated $756K sold.

Piedmont Investment Advisors first reported a position in INGN in Q2 2017 and held it in 5 quarters. The position peaked at $756K in Q2 2018. 281 funds tracked by Wall St. Rank hold INGN as of Q3 2018.

Piedmont Investment Advisors reported no remaining Inogen position as of Q3 2018 after selling out during the quarter.
Piedmont Investment Advisors sold 4,059 Inogen shares in Q3 2018, an estimated $756K.
Piedmont Investment Advisors first reported a position in Inogen in Q2 2017 and held it in 5 quarters.
Piedmont Investment Advisors's Inogen position peaked at $756K in Q2 2018.
281 funds tracked by Wall St. Rank held Inogen as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.